A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid

NCT05267600 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Bullous Pemphigoid

Interventions

BIOLOGICAL: efgartigimod PH20 SC
OTHER: placebo
DRUG: Prednisone

Sponsor

argenx